Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Randomized Phase III Study to Assess the Effect of a Longer Duration of Consolidation Treatment With Nilotinib on TFR in CP CML. (NCT01743989) | Novartis Pharmaceuticals | 2013-04-15 |
Track Philadelphia Chromosome Positive (PH+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) automatically
Every clearance here is in the API, with alerts when new ones post.